zolpidem has been researched along with Cannabis Abuse in 4 studies
Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Self-report measures of recent sleep, Insomnia Severity Index (ISI), and drug use (Timeline Follow-Back) were collected at each study visit, and the study confirmed self-reported abstinence via quantitative urine drug testing." | 3.83 | Randomized controlled trial of zolpidem as a pharmacotherapy for cannabis use disorder. ( Budney, AJ; Hampson, AJ; Herrmann, ES; Lee, DC; Leoutsakos, J; Martin, EL; Schlienz, NJ; Smith, MT; Tompkins, DA; Vandrey, R, 2024) |
| "This placebo-controlled study examined the effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory measure of relapse." | 2.82 | Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users. ( Bedi, G; Comer, SD; Cooper, ZD; Foltin, RW; Haney, M; Herrmann, ES; Ramesh, D; Reed, SC, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, DC | 1 |
| Schlienz, NJ | 1 |
| Herrmann, ES | 2 |
| Martin, EL | 1 |
| Leoutsakos, J | 1 |
| Budney, AJ | 1 |
| Smith, MT | 1 |
| Tompkins, DA | 1 |
| Hampson, AJ | 1 |
| Vandrey, R | 2 |
| Cooper, ZD | 1 |
| Bedi, G | 1 |
| Ramesh, D | 1 |
| Reed, SC | 1 |
| Comer, SD | 1 |
| Foltin, RW | 2 |
| Haney, M | 2 |
| Umbricht, A | 1 |
| Strain, EC | 1 |
| Vadhan, NP | 1 |
| Hart, CL | 1 |
| Roe, B | 1 |
| Colley, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effect of Marijuana and Prescription Medications in Mood, Performance and Sleep[NCT00893269] | Phase 1 | 36 participants (Actual) | Interventional | 2008-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for zolpidem and Cannabis Abuse
| Article | Year |
|---|---|
Randomized controlled trial of zolpidem as a pharmacotherapy for cannabis use disorder.
Topics: Adult; Humans; Hypnotics and Sedatives; Marijuana Abuse; Sleep; Sleep Initiation and Maintenance Dis | 2024 |
Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users.
Topics: Adult; Affect; Anti-Anxiety Agents; Cognition; Dose-Response Relationship, Drug; Double-Blind Method | 2016 |
Increased blood pressure after abrupt cessation of daily cannabis use.
Topics: Adult; Blood Pressure; Cross-Over Studies; Dronabinol; Female; Heart Rate; Humans; Hypnotics and Sed | 2011 |
1 other study available for zolpidem and Cannabis Abuse
| Article | Year |
|---|---|
Substance use and psychosocial outcomes following participation in residential laboratory studies of marijuana, methamphetamine and zolpidem.
Topics: Alcoholism; Costs and Cost Analysis; Dopamine Agents; Humans; Hypnotics and Sedatives; Marijuana Abu | 2006 |